Upgrade to SI Premium - Free Trial

Edwards Lifesciences (EW): TAVR Outperformance Drives A PT Increase - Cowen

July 27, 2017 6:49 AM
Cowen analyst, Joshua Jennings, reiterated his Outperform rating on shares of Edwards Lifesciences (NYSE: EW) and raised his price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles